Exploring Nanotechnology in Cardiovascular Disease Treatment Research

This research proposal aims to explore the effectiveness and trends in using nanotechnology for the prevention, diagnosis, and treatment of cardiovascular disease, focusing on its impact on the quality of life compared to traditional treatments like oral medications and invasive surgeries. The study employs a quantitative, retrospective, cross-sectional research design, involving a survey of cardiologists and heart surgeons to gather their views on nanotechnology's role in treating cardiovascular ailments and improving patient quality of life. Additional data on mortality rates among cardiovascular disease patients receiving nanotechnology versus open-heart surgery will be collected across different age groups. The anticipated results will be tested against the hypothesis that nanotechnology is an effective cardiovascular treatment, improving mortality rates and quality of life compared to traditional interventions. Ultimately, this study seeks to provide insights into healthcare technology trends and pave the way for future innovations in cardiovascular treatment and improved health outcomes.

Running head: RESEARCH PROPOSAL OUTLINE
RESEARCH PROPOSAL OUTLINE
Name of the Student:
Name of the University:
Author note:

1RESEARCH PROPOSAL OUTLINE
Research Objective
The aim of the following research is to explore the current effectiveness and trends
underlying the usage of nanotechnology for the prevention, diagnosis and treatment of
cardiovascular disease with an objective to understand its effect on quality of life as
compared to patients receiving oral medications or invasive heart surgeries.
Background
With rising trends in obesity, lifestyle and occupational stresses and inadequate
dietary intake, rates of cardiovascular diseases are rising despite well-established treatments
in terms oral medications and invasive surgeries (Prajnamitra et al., 2019). Nanotechnology
proves to be a promising innovative intervention in this respect, which can improve life-
threatening, atherosclerotic conditions like thrombosis, vasoconstriction and inflammation
through biologically potent nanoparticles like dendrimers, micelles and liposomes
(Chandarana, Curtis & Hoskins, 2018).
Methodology
A quantitative, retrospective, cross sectional research design will be used, which will
firstly involve a survey exploring the views, opinions and standards followed by health
professionals, preferably cardiologists and heart surgeons on the usage of nanotechnology
for treatment and improving the quality of life in patients with cardiovascular ailments.
Additional data on the mortality rate of cardiovascular disease patients, across the age groups
of below 40 as well as above 40 years of age, receiving nanotechnology in comparison to
open-heart surgery will be collected.

2RESEARCH PROPOSAL OUTLINE
Results
The responses obtained from the survey will be tested against the proposed
hypothesis: Nanotechnology is an effective cardiovascular treatment in the improvement of
mortality rate and quality of life in patients as compared to traditional cardiovascular
interventions such as invasive surgical procedures and oral medications.
Conclusion
This study will provide and insights on current trends in healthcare technology and
will pave the way for future innovation in cardiovascular treatment and improved health
outcomes in patients.

3RESEARCH PROPOSAL OUTLINE
References
Chandarana, M., Curtis, A., & Hoskins, C. (2018). The use of nanotechnology in
cardiovascular disease. Applied Nanoscience, 8(7), 1607-1619.
Prajnamitra, R. P., Chen, H. C., Lin, C. J., Chen, L. L., & Hsieh, P. C. H. (2019).
Nanotechnology Approaches in Tackling Cardiovascular Diseases. Molecules, 24(10),
2017.